These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 29436100)
41. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells. Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639 [TBL] [Abstract][Full Text] [Related]
42. Chemoimmunotherapy by combining oxaliplatin with immune checkpoint blockades reduced tumor burden in colorectal cancer animal model. Wang W; Wu L; Zhang J; Wu H; Han E; Guo Q Biochem Biophys Res Commun; 2017 May; 487(1):1-7. PubMed ID: 28042031 [TBL] [Abstract][Full Text] [Related]
43. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation. Yakisich JS; Venkatadri R; Azad N; Iyer AKV J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932 [TBL] [Abstract][Full Text] [Related]
44. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer. Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226 [TBL] [Abstract][Full Text] [Related]
45. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer. Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509 [TBL] [Abstract][Full Text] [Related]
46. A role for ABCG2 beyond drug transport: Regulation of autophagy. Ding R; Jin S; Pabon K; Scotto KW Autophagy; 2016 May; 12(5):737-51. PubMed ID: 26983466 [TBL] [Abstract][Full Text] [Related]
47. miR-135a promotes gastric cancer progression and resistance to oxaliplatin. Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111 [TBL] [Abstract][Full Text] [Related]
48. Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer. Sui H; Duan P; Guo P; Hao L; Liu X; Zhang J; Zhu H; Zhao M; Wang H; Li Q; Wang S Oncol Rep; 2017 Oct; 38(4):2087-2095. PubMed ID: 28849164 [TBL] [Abstract][Full Text] [Related]
49. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2. Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875 [TBL] [Abstract][Full Text] [Related]
50. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer. Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572 [TBL] [Abstract][Full Text] [Related]
51. CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer. Bhattacharyya S; Sekar V; Majumder B; Mehrotra DG; Banerjee S; Bhowmick AK; Alam N; Mandal GK; Biswas J; Majumder PK; Murmu N Cell Oncol (Dordr); 2017 Apr; 40(2):145-155. PubMed ID: 28039610 [TBL] [Abstract][Full Text] [Related]
52. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. Spitzwieser M; Pirker C; Koblmüller B; Pfeiler G; Hacker S; Berger W; Heffeter P; Cichna-Markl M Oncotarget; 2016 Nov; 7(45):73347-73369. PubMed ID: 27689338 [TBL] [Abstract][Full Text] [Related]
53. Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NFkappaB signaling pathways. Prasad S; Madan E; Nigam N; Roy P; George J; Shukla Y Cancer Biol Ther; 2009 Sep; 8(17):1632-9. PubMed ID: 19625778 [TBL] [Abstract][Full Text] [Related]
54. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines. Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326 [TBL] [Abstract][Full Text] [Related]
55. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis. Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151 [TBL] [Abstract][Full Text] [Related]
56. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression. Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310 [TBL] [Abstract][Full Text] [Related]
57. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer. Lin H; Luo Y; Gong T; Fang H; Li H; Ye G; Zhang Y; Zhong M Cell Oncol (Dordr); 2024 Aug; 47(4):1149-1165. PubMed ID: 38386232 [TBL] [Abstract][Full Text] [Related]
58. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965 [TBL] [Abstract][Full Text] [Related]
59. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
60. Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways. Liu Y; Bi T; Wang G; Dai W; Wu G; Qian L; Gao Q; Shen G Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):295-304. PubMed ID: 25418891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]